Market Overview:
The global serum-free cell freezing medium market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for serum-free cell freezing media from academic research institutions and pharmaceutical biotechnology companies. North America is expected to dominate the market during the forecast period, followed by Europe and Asia Pacific. Latin America and Middle East & Africa are expected to grow at a high CAGR during the forecast period.
Product Definition:
A serum-free freezing medium is a type of cell culture media that does not contain serum. Serum-free freezing media are often used to freeze cells, tissues, or embryos.
With DMSO:
With DMSO, it's usage and growth factor in serum-free cell freezing medium market. Serum-free means that the medium does not contain blood cells or plasma of any kind. The main function of such a medium is to protect the cells from damage due to extremely low temperatures (below -80°C), which are usually employed for cell cryopreservation and long-term storage.
Without DMSO:
DMSO is a solvent, which stands for dimethyl sulfoxide. It is colorless and has a mild odor. DMSO can be made in laboratories by the reaction of sulfuric acid with methanol. Methanol and sulfuric acid are both easily available at any chemical supply house or supermarket (for example, IBC handbook).
Application Insights:
The academic research institutions segment held the largest revenue share of over 60% in 2017. The demand for serum-free cell freezing medium is high in this segment as it helps maintain cellular and molecular integrity during the process of freezing and storage. Moreover, these products are used for preservation of tissue samples that contain stem cells at a higher rate which boosts its demand further.
The pharmaceutical biotechnology company application held a significant revenue share in 2017 owing to increased R&D activities pertaining to advanced medicines and vaccines across the globe. This factor has boosted the usage of cell suspension culture techniques such as monolayer cultivation, transfection, transduction etc., which requires frozen cultures at specific developmental stages along with media supplements during re-suspension into liquid nitrogen tanks or ice cube trays respectively. These processes require an extensive amount of serum-free mediums thus driving its market growth over recent years (decade).
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing R&D activities and presence of a large number of biotechnology and pharmaceutical companies. In addition, government support for research & development activities is also anticipated to propel growth over the coming years.
Asia Pacific is estimated to be one of the fastest-growing regions during the forecast period due to rising investments by various organizations in this region coupled with growing awareness regarding cell freezing mediums among researchers from developing economies such as India and China. Moreover, initiatives taken by governments across countries are also expected favorably impact regional market growth over next few years.
Growth Factors:
- Increasing demand for stem cell therapies and regenerative medicine
- Growing number of biotechnology and pharmaceutical companies
- Rising investment in research and development by academic institutions and private organizations
- Technological advancements in cell-free freezing mediums
- Increasing focus on personalized medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Serum-Free Cell Freezing Medium Market Research Report
By Type
With DMSO, Without DMSO
By Application
Academic Research Institutions, Pharmaceutical Biotechnology Company
By Companies
Thermo Fisher, Merck, Zenoaq, STEMCELL, GE Healthcare, BioLifeSolutions, Bio-Techne, Lonza, Biological Industries, Nippon Genetics, HiMedia, PromoCell
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Serum-Free Cell Freezing Medium Market Report Segments:
The global Serum-Free Cell Freezing Medium market is segmented on the basis of:
Types
With DMSO, Without DMSO
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Research Institutions, Pharmaceutical Biotechnology Company
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Merck
- Zenoaq
- STEMCELL
- GE Healthcare
- BioLifeSolutions
- Bio-Techne
- Lonza
- Biological Industries
- Nippon Genetics
- HiMedia
- PromoCell
Highlights of The Serum-Free Cell Freezing Medium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- With DMSO
- Without DMSO
- By Application:
- Academic Research Institutions
- Pharmaceutical Biotechnology Company
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Serum-Free Cell Freezing Medium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Serum-free cell freezing medium (SFM) is a type of cell culture media that does not contain serum. SFM is used to freeze cells and tissues for later use in research or therapy.
Some of the major companies in the serum-free cell freezing medium market are Thermo Fisher, Merck, Zenoaq, STEMCELL, GE Healthcare, BioLifeSolutions, Bio-Techne, Lonza, Biological Industries, Nippon Genetics, HiMedia, PromoCell.
The serum-free cell freezing medium market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Serum-Free Cell Freezing Medium Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Serum-Free Cell Freezing Medium Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Serum-Free Cell Freezing Medium Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Serum-Free Cell Freezing Medium Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Serum-Free Cell Freezing Medium Market Size & Forecast, 2020-2028
4.5.1 Serum-Free Cell Freezing Medium Market Size and Y-o-Y Growth
4.5.2 Serum-Free Cell Freezing Medium Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 With DMSO
5.2.2 Without DMSO
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Academic Research Institutions
6.2.2 Pharmaceutical Biotechnology Company
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Serum-Free Cell Freezing Medium Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Serum-Free Cell Freezing Medium Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 With DMSO
9.6.2 Without DMSO
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Academic Research Institutions
9.10.2 Pharmaceutical Biotechnology Company
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 With DMSO
10.6.2 Without DMSO
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Academic Research Institutions
10.10.2 Pharmaceutical Biotechnology Company
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 With DMSO
11.6.2 Without DMSO
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Academic Research Institutions
11.10.2 Pharmaceutical Biotechnology Company
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 With DMSO
12.6.2 Without DMSO
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Academic Research Institutions
12.10.2 Pharmaceutical Biotechnology Company
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 With DMSO
13.6.2 Without DMSO
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Academic Research Institutions
13.10.2 Pharmaceutical Biotechnology Company
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Serum-Free Cell Freezing Medium Market: Competitive Dashboard
14.2 Global Serum-Free Cell Freezing Medium Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher
14.3.2 Merck
14.3.3 Zenoaq
14.3.4 STEMCELL
14.3.5 GE Healthcare
14.3.6 BioLifeSolutions
14.3.7 Bio-Techne
14.3.8 Lonza
14.3.9 Biological Industries
14.3.10 Nippon Genetics
14.3.11 HiMedia
14.3.12 PromoCell
